IMM 1.56% 31.5¢ immutep limited

trading analysis is prr positive, page-8

  1. 459 Posts.
    lightbulb Created with Sketch. 7
    Some time after 9am on Tuesday 21st July 2009.

    Announcement after a trading halt:

    'PRIMA BIOMED COMPLETES A$25.5 MILLION CONVERTIBLE NOTE
    FUNDING'

    Funding has been Prima Biomeds biggest issue which is why it reached a SP of 0.005 and anyone who has had a look at their balance sheets and not seen $20m or so to spend on trials and development should realise they need the money from somewhere and that dilution will occur and this SHOULD already be factored in to some degree.

    Hope this helps

    Regards

    dc
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.